Fidelity MSCI Health Care ETF holds a quantitatively derived Bronze Morningstar Medalist Rating. The rating reflects that it has scored better than the norm on factors Morningstar research associates with future outperformance relative to category peers.
Fidelity MSCI Health Care Index ETF FHLC
Morningstar’s Analysis FHLC
Will FHLC outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the FHLC management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of FHLC’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 52.0
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Eli Lilly and Co | 14.12 | 430M | Healthcare |
Johnson & Johnson | 8.89 | 271M | Healthcare |
AbbVie Inc | 6.15 | 187M | Healthcare |
UnitedHealth Group Inc | 5.72 | 174M | Healthcare |
Merck & Co Inc | 4.55 | 139M | Healthcare |
Amgen Inc | 2.82 | 86M | Healthcare |
Thermo Fisher Scientific Inc | 2.77 | 84M | Healthcare |
Abbott Laboratories | 2.40 | 73M | Healthcare |
Gilead Sciences Inc | 2.33 | 71M | Healthcare |
Intuitive Surgical Inc | 2.26 | 69M | Healthcare |
United States